Characterizing DNA methylation patterns in pancreatic cancer genome
Aik Choon Tan, Antonio Jimeno, Steven Hsesheng Lin et al. · Molecular Oncology · 2009
We performed a global methylation profiling assay on 1505 CpG sites across 807 genes to characterize DNA methylation patterns in pancreatic cancer genome. We found 289 CpG sites that were differentially methylated in normal pancreas, pancreatic tumors and cancer cell lines. We identified 23 and 35 candidate genes that are regulated by hypermethylation and hypomethylation in pancreatic cancer, respectively. We also identified candidate methylation markers that alter the expression of genes critical to gemcitabine susceptibility in pancreatic cancer. These results indicate that aberrant DNA methylation is a frequent epigenetic event in pancreatic cancer; and by using global methylation profiling assay, it is possible to identify these markers for diagnostic and therapeutic purposes in this disease.
Cited by 159 works. doi:10.1016/j.molonc.2009.03.004 Open-access PDF
Authors
- Aik Choon Tan
- Antonio Jimeno
- Steven Hsesheng Lin
- Jenna Wheelhouse
- Fonda Chan
- Anna Solomon
- N.V. Rajeshkumar
- Belén Rubio‐Viqueira
- Manuel M. Hidalgo
References
- Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
- In silico prediction of protein-protein interactions in human macrophages
- Significance analysis of microarrays applied to the ionizing radiation response
- Cancer Statistics, 2007
- The fundamental role of epigenetic events in cancer
- Open source clustering software
- Inactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents
- Gene Silencing in Cancer in Association with Promoter Hypermethylation
- Java Treeview—extensible visualization of microarray data
- A gene hypermethylation profile of human cancer.